ARTECEL Trademark

Trademark Overview

On Thursday, March 20, 2003, a trademark application was filed for ARTECEL with the United States Patent and Trademark Office. The USPTO has given the ARTECEL trademark a serial number of 78228219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, May 19, 2007. This trademark is owned by Cognate Therapeutics, Inc.. The ARTECEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research for new therapeutic products for others; and testing of therapeutics products for others

General Information

Serial Number78228219
Word MarkARTECEL
Filing DateThursday, March 20, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, May 19, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 24, 2004

Trademark Statements

Goods and ServicesResearch for new therapeutic products for others; and testing of therapeutics products for others
Pseudo MarkART EXCEL

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 2, 2003
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameARTECEL, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSUNNYVALE, CA 94086
Party NameCognate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94086
Party NameCognate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSunnyvale, CA 94086

Trademark Events

Event DateEvent Description
Wednesday, December 5, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, December 5, 2007ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 11, 2007EXTENSION 5 GRANTED
Friday, November 17, 2006EXTENSION 5 FILED
Friday, November 17, 2006TEAS EXTENSION RECEIVED
Sunday, June 18, 2006EXTENSION 4 GRANTED
Thursday, May 18, 2006EXTENSION 4 FILED
Monday, July 31, 2006EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 31, 2006PETITION TO REVIVE-GRANTED
Monday, July 31, 2006TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 18, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, July 18, 2006ABANDONMENT - NO USE STATEMENT FILED
Sunday, December 18, 2005EXTENSION 3 GRANTED
Friday, November 18, 2005EXTENSION 3 FILED
Thursday, May 18, 2006EXTENSION RECEIVED WITH TEAS PETITION
Thursday, May 18, 2006PETITION TO REVIVE-GRANTED
Thursday, May 18, 2006TEAS PETITION TO REVIVE RECEIVED
Thursday, May 18, 2006FAX RECEIVED
Wednesday, April 19, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, April 19, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 11, 2006REVIEW OF CORRESPONDENCE COMPLETE
Friday, September 2, 2005PAPER RECEIVED
Tuesday, May 31, 2005EXTENSION 2 GRANTED
Sunday, May 15, 2005EXTENSION 2 FILED
Sunday, May 15, 2005TEAS EXTENSION RECEIVED
Sunday, April 10, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 19, 2004EXTENSION 1 GRANTED
Friday, November 12, 2004EXTENSION 1 FILED
Friday, November 12, 2004TEAS EXTENSION RECEIVED
Tuesday, May 18, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 24, 2004PUBLISHED FOR OPPOSITION
Wednesday, February 4, 2004NOTICE OF PUBLICATION
Wednesday, November 26, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 7, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 9, 2003PAPER RECEIVED
Thursday, September 18, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 16, 2003NON-FINAL ACTION E-MAILED
Saturday, September 13, 2003ASSIGNED TO EXAMINER

Related Keywords

artecel others products therapeutics testing therapeutic research